RE:RE:RE:RE:RE:RE:RE:My take on the current low ppsIf Prometic can get Ryplazim's BLA followed by IVIG's BLA, then they will be cash flow positive. From what I understand and calculate based on Prometic's PPPS capacity, only the IVIG could fund the cie by itself and will be sold as soon as out of PPPS facility with no salesforce needed. Some analyst agree with this too as seen in the Q/A in the last CC.
Since these 2 events are coming soon, Ryplazim in a couple of weeks or less and IVIG within a year more or less, and with Thomvest credit line plus revenu from resine, Ryplazim etc, I agree with you and the management and many analists that they must keep their IP as much as possible than signed a deal now to please some shareholders with a short view and give away a large percentage of the IP forever.
With the BLA of ryplazim coming in less than 36 trading days max and the release of Alstrom data for 60 to 84 weeks (more or less depending on the patient), it should bring confidence and credibility to both PPPS and 4050.
Then the shorts will have to cover because it will be hard to try to convince the market that the SP should stay low as it is now so they wont have other choice than cover especially if they also get the PRV.
And once again, this should come in less than 36 trading days.
With the last news very well worked on by the management and being put out there at this exact moment chosen by them, there has to be something more cooking very soon.
Eric